• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Astrotech Corporation Submits Proposal to NASA's Commercial Lunar Payload Services 2 Program

    6/30/26 8:30:00 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Get the next $ASTC alert in real time by email







    AUSTIN, Texas, June 30, 2026 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) ("Astrotech" or the "Company"), a science and technology company with prior deep operational spaceflight heritage, today announced that it has submitted a proposal to NASA under the agency's Commercial Lunar Payload Services 2 ("CLPS2") program. Astrotech's Phase 1 proposal seeks approximately $20 million in non-dilutive NASA funding to support the initial stage of a proposed lunar technology demonstration program. The Company estimates that it would seek additional NASA funding from the CLPS2 program for this initiative if fully implemented and authorized by NASA. CLPS2 is structured as a multiple-award procurement program for commercial payload delivery and related mission services, with a reported budget for all awarded contracts of up to $10 billion.

    Astrotech's proposal submission for technology demonstrations represents an important step in the Company's strategy to participate in the emerging commercial lunar infrastructure market and support future operations on the Moon.

    Astrotech's CLPS2 proposal is part of the Company's broader lunar resources and infrastructure initiative, which is focused on evaluating and developing technologies and partnerships that could support lunar resource extraction, materials processing, autonomous industrial operations, oxygen production, silicon-28 ("Si-28") production, platinum group metals recovery, quantum wafer manufacturing, AI-enabled process control, a lunar commercial communications hub, solar-electric power generation, potential future nuclear power generation, and other advanced manufacturing applications that may benefit from the Moon's unique operating environment, including ultra-high vacuum conditions.

    "Submitting this CLPS2 proposal formally introduces Astrotech's vision for a lunar industrial economy and marks the return to the Company's prior spaceflight heritage," said Thomas B. Pickens III, Chairman, Chief Executive Officer and Chief Technology Officer of Astrotech Corporation. "Astrotech previously identified what it believes to be significant long-term commercial value on the Moon, but the transportation infrastructure required to pursue that vision did not yet exist at the scale, cadence or cost structure needed to support a serious lunar industrial strategy. Today, with the growth of commercial launch and lander capabilities, NASA's Artemis campaign, and the CLPS and CLPS2 programs, we believe the foundation is being established for a new era of lunar industrial development.

    "Our Phase 1 proposal seeks approximately $20 million from NASA to demonstrate key lunar mining and materials processing technologies. Our long-term objective is to support the extraction and processing of critical lunar resources, development of lunar power and equipment support services, and advanced manufacturing on the Moon, including the potential production of ultra-high-purity silicon wafers for quantum computing, AI and advanced semiconductor applications. We believe NASA's CLPS framework gives American companies a path to expand commercial lunar capabilities, and Astrotech seeks to be part of this Moon commercialization."

    Astrotech's long-term lunar strategy contemplates a recurring-mission architecture designed to support the identification, extraction, transfer, processing and potential commercialization of lunar resources. The Company intends to pursue technologies and partnerships supporting autonomous excavation, lunar surface mobility, regolith handling, sealed material transfer, process control, thermal processing, advanced materials development for quantum computing and AI applications, and potential deployment of lunar processing, smelting or refining systems on the Moon.

    Astrotech's lunar initiative is structured as a return to its prior spaceflight legacy spanning the Space Shuttle, Mir, International Space Station, commercial cargo and satellite-processing eras. This heritage includes the Company’s prior operations working with SPACEHAB, pressurized modules that supported Shuttle-era research, cargo and logistics missions. SPACEHAB hardware flew aboard Space Shuttle missions carrying experiments and supplies to low Earth orbit, Mir and the International Space Station.

    "Operating beyond Earth demands discipline, reliability and experience," Pickens added. A successful lunar industrial venture will not be built on a single mission; it will require recurring missions, proven hardware and disciplined execution over time. Through our prior space operations heritage and Shuttle-era flight experience, Pickens has had experience with complex space missions repeatedly. We believe that experience is central to our strategy for lunar mining, materials processing, power generation and advanced manufacturing opportunities, including quantum computing and AI applications. "

    Astrotech is not disclosing confidential details of its CLPS2 proposal, including proprietary technical architecture. Submission of the proposal does not constitute a NASA selection, award, contract, authorization, endorsement or commitment. Any selection, task order or funding, if made, would be made by NASA in accordance with applicable procurement rules.

    About Astrotech Corporation

    Astrotech Corporation (NASDAQ:ASTC) is a science and technology company headquartered in Austin, Texas. The Company creates, operates and scales innovative businesses through its subsidiaries and technology platforms, including space-related technology, advanced instrumentation, mass spectrometry, gas chromatography, process-control and environmental analysis technologies. Astrotech is evaluating opportunities to identify, develop and commercialize advanced technologies with potential applications in space, defense, industrial, environmental, quantum computing, AI, advanced semiconductor materials, lunar infrastructure and related markets.

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements regarding Astrotech's CLPS2 proposal; potential selection, award, task order issuance, Phase 1 funding from NASA, NASA funding for the estimated total proposed program requirement, NASA procurement ceilings, or performance under any NASA procurement; the Company's strategic lunar resources and infrastructure initiative; potential lunar mining, resource extraction, materials processing, smelting, refining, solar-electric power generation, future nuclear power generation, power sales, utility-style power services, commercial communications infrastructure, autonomous systems, Si-28, lunar-use oxygen, platinum group metals, quantum computing, AI, advanced semiconductor materials, future lunar base support, lunar transportation, recurring lunar missions, lunar surface operations, customer demand, partnerships, NASA funding, commercialization, and future lunar industrial activity; and the Company's ability to develop, validate, obtain NASA funding for, launch, operate, or commercialize any space-related technology or infrastructure.

    Forward-looking statements may be identified by words such as "aims," "anticipates," "believes," "could," "expects," "intends," "may," "plans," "potential," "proposes," "seeks," "should," "targets," "will," "would," and similar expressions. These statements are based on current expectations, estimates, forecasts and assumptions and are subject to significant risks and uncertainties, many of which are beyond the Company's control.

    Risks and uncertainties include, among others, the possibility that NASA does not select Astrotech for any CLPS2 award, task order or Phase 1 funding; the possibility that Astrotech does not receive approximately $20 million in Phase 1 funding from NASA, or additional NASA funding from CLPS2 for the proposed program, any other NASA funding, or any contract from NASA; the early-stage nature of the Company's lunar resources and infrastructure initiative; technical, engineering, regulatory, licensing, operational, launch, landing, mission, cost, NASA funding, supply-chain, resource-characterization, market and commercial risks; additional risks associated with any future nuclear power systems, including safety, regulatory, licensing, launch, mission, operations, partner and customer requirements; uncertainty regarding any future quantum-computing, AI or advanced semiconductor market opportunity; the availability and cost of lunar transportation and surface operations; the Company's ability to secure strategic partners, customers, government support or NASA funding; uncertainty regarding the existence, concentration, accessibility, extractability, processing, ownership, regulation and commercial value of lunar resources; and other risks described in the Company's filings with the Securities and Exchange Commission including the Company’s most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Any forward-looking statements in this document should be evaluated in light of these important risk factors. Any such effects may give rise to risks and uncertainties that are currently unknown or amplify others mentioned herein. Although the Company believes the expectations reflected in its forward-looking statements are reasonable and are based on reasonable assumptions, no assurance can be given that these assumptions are accurate or that any of these expectations will be achieved (in full or at all) or will prove to have been correct. Moreover, such statements are subject to a number of assumptions, risks and uncertainties, many of which are beyond the control of the Company, which may cause actual results to differ materially from those implied or expressed by the forward-looking statements.

    No assurance can be given that Astrotech will receive a NASA award, task order, Phase 1 funding from NASA, or additional NASA funding from CLPS2 for the proposed program, or any portion of any NASA procurement ceiling; successfully develop lunar mining or processing systems; deploy lunar processing, smelting or refining systems; build lunar solar-electric or nuclear power infrastructure; provide utility-style lunar power services; support a future lunar base; develop or commercialize Si-28, quantum-computing, AI or advanced semiconductor applications; sell power, materials or services to third parties; or achieve any of the objectives described in this release. Forward-looking statements speak only as of the date of this release. Astrotech undertakes no obligation to update or revise any forward-looking statements except as required by law.

    Contacts

    Company Contact:

    Scott Bartley

    Interim Chief Financial Officer

    Astrotech Corporation

    (512) 485-9530



    Investor Relations Contact:

    Matt Kreps

    Managing Director, Darrow Associates

    (214) 597-8200

    mkreps@darrowir.com












    Primary Logo

    Get the next $ASTC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ASTC

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ASTC
    SEC Filings

    View All

    SEC Form EFFECT filed by Astrotech Corporation (DE)

    EFFECT - ASTROTECH Corp (0001001907) (Filer)

    7/8/26 12:15:17 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form S-3 filed by Astrotech Corporation (DE)

    S-3 - ASTROTECH Corp (0001001907) (Filer)

    6/30/26 6:02:46 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech Corporation (DE) filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - ASTROTECH Corp (0001001907) (Filer)

    6/16/26 8:32:55 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ASTC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Halinski John William was granted 1,055 shares, increasing direct ownership by 9% to 12,211 units (SEC Form 4)

    4 - ASTROTECH Corp (0001001907) (Issuer)

    7/21/26 4:42:22 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Director Winn Charles Arch was granted 1,055 shares, increasing direct ownership by 11% to 10,950 units (SEC Form 4)

    4 - ASTROTECH Corp (0001001907) (Issuer)

    7/21/26 4:40:11 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Director Mcfarland Robert N was granted 1,055 shares, increasing direct ownership by 10% to 11,205 units (SEC Form 4)

    4 - ASTROTECH Corp (0001001907) (Issuer)

    7/21/26 4:38:48 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ASTC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Astrotech Corporation Submits Proposal to NASA's Commercial Lunar Payload Services 2 Program

    AUSTIN, Texas, June 30, 2026 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) ("Astrotech" or the "Company"), a science and technology company with prior deep operational spaceflight heritage, today announced that it has submitted a proposal to NASA under the agency's Commercial Lunar Payload Services 2 ("CLPS2") program. Astrotech's Phase 1 proposal seeks approximately $20 million in non-dilutive NASA funding to support the initial stage of a proposed lunar technology demonstration program. The Company estimates that it would seek additional NASA funding from the CLPS2 program for this initiative if fully implemented and authorized by NASA. CLPS2 is structured as a multipl

    6/30/26 8:30:00 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech Board Approves Potential Sale Process of 1st Detect and TRACER 1000, the Only Field-Deployed Mass Spectrometry ETD, as the Company Focuses on Its Initiative in Space

    AUSTIN, Texas, June 16, 2026 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) ("Astrotech" or the "Company") today announced that its Board of Directors has approved a potential sale process of its 1st Detect Corporation subsidiary ("1st Detect"), developer of the TRACER 1000 mass spectrometry–based explosives and narcotics trace detection ("ETD") platform. The TRACER 1000 is the only mass spectrometry ETD certified and field-deployed in aviation security operations, at a moment when U.S. and European authorities have signaled a shift away from the legacy ion mobility spectrometry ("IMS") technology that has dominated the market for three decades. The Company is evaluating a potenti

    6/16/26 8:30:00 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech Corporation's 1st Detect TRACER 1000 Receives ECAC Certification for Wand Swabbing

    AUSTIN, Texas, June 08, 2026 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) (the "Company" or "Astrotech") announced today that its 1st Detect TRACER 1000 system has received the European Civil Aviation Conference ("ECAC") certification for wand swabbing, approved for use in screening both passengers and cargo in aviation security operations. "Wand swabbing certification extends our TRACER 1000 customer base to include airports that require wand swabbing," said Tom Pickens, Chairman and CEO of Astrotech Corporation. "We believe our technology allows for a less intrusive method of passenger testing, while also reducing bottlenecks, allowing airports to process more passengers wit

    6/8/26 8:30:00 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ASTC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Becker James Frank bought $19,675 worth of shares (2,034 units at $9.67), increasing direct ownership by 14% to 16,121 units (SEC Form 4)

    4 - ASTROTECH Corp (0001001907) (Issuer)

    5/30/24 9:16:58 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Hinojosa Jaime bought $8,541 worth of shares (900 units at $9.49), increasing direct ownership by 13% to 7,881 units (SEC Form 4)

    4 - ASTROTECH Corp (0001001907) (Issuer)

    5/28/24 9:46:54 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Wilkinson Thomas Wiley bought $10,536 worth of shares (1,109 units at $9.50), increasing direct ownership by 6% to 20,862 units (SEC Form 4)

    4 - ASTROTECH Corp (0001001907) (Issuer)

    5/21/24 12:54:36 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ASTC
    Leadership Updates

    Live Leadership Updates

    View All

    Astrotech Reports Second Quarter of Fiscal Year 2026 Financial Results

    AUSTIN, Texas, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) (the "Company" or "Astrotech") reported its financial results for the second quarter of fiscal year 2026, which ended December 31, 2025. Financial Highlights & Recent Developments Research and development expense was $1,832 thousand, a decline of 25% from the second quarter of fiscal year 2025 as the Company transitions from development stage to saleable products for its EN-SCAN Handheld GC and 1st Detect Tracer 1000 product lines.Through December 31, 2025, the Company has deployed the TRACER 1000 trace detection system in approximately 35 locations in 16 countries across the United States, Europe and As

    2/13/26 8:15:00 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech Subsidiary 1st Detect Appoints Industry Veteran David Spada as Director of Global Sales to Expand Global Reach of TRACER 1000™

    AUSTIN, Texas, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) (the "Company" or "Astrotech") today announced that its subsidiary, 1st Detect Corporation ("1st Detect"), has appointed industry veteran, David Spada, as Director of Global Sales. This strategic hire strengthens 1st Detect's commercial leadership as the company scales deployment of its TRACER 1000™ mass spectrometry-based explosives and narcotics trace detector across international security markets. Mr. Spada brings over a decade of specialized trace detection experience to the 1st Detect team. Throughout his career at Implant Sciences, Morpho Detection, and Rapiscan Systems, Mr. Spada has held position

    1/21/26 4:15:00 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech Corporation Appoints Scott Bartley as Interim Chief Financial Officer

    AUSTIN, Texas, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) (the "Company" or ("Astrotech"), today announced that it has appointed Scott Bartley as Interim Chief Financial Officer ("CFO") of the Company, effective as of October 20, 2025. "We are pleased to announce Scott Bartley as Chief Financial Officer," stated Thomas B. Pickens III, Chairman and Chief Executive Officer of Astrotech Corporation. "He brings over two decades of expertise as a Controller and CFO, across multiple industries, providing important qualification and vantage points for our business across multiple end markets."​Mr. Bartley, age 56, has served as a financial consultant since 2011, inclu

    10/31/25 4:15:00 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ASTC
    Financials

    Live finance-specific insights

    View All

    Astrotech Announces Listing to the GSA as an Approved United States Government Vendor

    Astrotech Announces Listing to the GSA as an Approved United States Government Vendor AUSTIN, Texas, April 08, 2024 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) ("Astrotech" or the "Company") and its wholly owned subsidiary, 1st Detect Corporation (1st Detect), announce that 1st Detect's TRACER 1000TM is now listed in the U.S. General Services Administration (GSA) IT Schedule 70 under Contract No. GS-35F-250GA with SRI Group LLC, Special Item Number 334290.   IT Schedule 70 is a long-term contract issued by the GSA to commercial technology vendors that allows sales to the U. S. federal government, one of the largest buyers of goods and services in the world. GSA's thoro

    4/8/24 9:00:00 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech to Showcase the Tracer 1000 Trace Detector at ISC West Conference

    AUSTIN, Texas, April 02, 2024 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) ("Astrotech" or the "Company") and its wholly owned subsidiary, 1st Detect Corporation, announces that it will be showcasing its TRACER 1000 Narcotics Trace Detector ("NTD") and Explosives Trace Detector ("ETD") at the International Security Conference and Exposition, also known as ISC West, in Las Vegas, Nevada, from April 9-12, 2024, in booth number 2067. The TRACER 1000 is a high-performance laboratory instrument that is powered by the Astrotech Mass Spectrometer Technology™ ("AMS Technology"). Our mass spectrometer is capable of rapid detection of trace levels of narcotic or explosive compounds in

    4/2/24 9:00:00 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech Introduces the "Gold Standard" of Mass Spectrometry into Narcotics Detection Market with its State-of-the-Art Tracer 1000

     AUSTIN, Texas, March 25, 2024 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) ("Astrotech" or the "Company") and its wholly owned subsidiary, 1st Detect Corporation, announces that it is currently accepting orders for the Tracer 1000 Narcotics Trace Detector (NTD). The TRACER 1000 NTD is a high-performance laboratory instrument capable of rapid detection of trace levels of narcotic compounds in seconds. Currently, the Company's Tracer 1000 Explosive Trace Detector (ETD) is now found in multiple locations in 14 countries throughout the world. The NTD provides a ruggedized platform that can be applied across various markets including airports, border security, checkpoint, cargo,

    3/25/24 9:00:00 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ASTC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by Astrotech Corporation (DE)

    SC 13D - ASTROTECH Corp (0001001907) (Subject)

    6/26/23 4:00:53 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form SC 13G/A filed by Astrotech Corporation (DE) (Amendment)

    SC 13G/A - ASTROTECH Corp (0001001907) (Subject)

    2/8/23 5:29:16 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form SC 13G/A filed by Astrotech Corporation (DE) (Amendment)

    SC 13G/A - ASTROTECH Corp (0001001907) (Subject)

    2/8/23 4:02:50 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials